TY - JOUR AU - Chang, L. S. AU - Barroso-Sousa, R. AU - Tolaney, S. M. AU - Hodi, F. S. AU - Kaiser, U. B. AU - Min, L. PY - 2019 DA - 2019// TI - Endocrine toxicity of cancer immunotherapy targeting immune checkpoints JO - Endocr Rev VL - 40 UR - https://doi.org/10.1210/er.2018-00006 DO - 10.1210/er.2018-00006 ID - Chang2019 ER - TY - JOUR AU - Tanvetyanon, T. AU - Gray, J. E. AU - Antonia, S. J. PY - 2017 DA - 2017// TI - PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer? JO - Expert Opin Biol Ther VL - 17 UR - https://doi.org/10.1080/14712598.2017.1280454 DO - 10.1080/14712598.2017.1280454 ID - Tanvetyanon2017 ER - TY - JOUR AU - Filette, J. AU - Andreescu, C. E. AU - Cools, F. AU - Bravenboer, B. AU - Velkeniers, B. PY - 2019 DA - 2019// TI - A systematic review and meta-analysis of endocrine-related adverse events associated with immune checkpoint inhibitors JO - Horm Metab Res VL - 51 UR - https://doi.org/10.1055/a-0843-3366 DO - 10.1055/a-0843-3366 ID - Filette2019 ER - TY - JOUR AU - Stamatouli, A. M. AU - Quandt, Z. AU - Perdigoto, A. L. AU - Clark, P. L. AU - Kluger, H. AU - Weiss, S. A. PY - 2018 DA - 2018// TI - Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors JO - Diabetes. VL - 67 UR - https://doi.org/10.2337/dbi18-0002 DO - 10.2337/dbi18-0002 ID - Stamatouli2018 ER - TY - JOUR AU - Filette, J. M. K. AU - Pen, J. J. AU - Decoster, L. AU - Vissers, T. AU - Bravenboer, B. AU - Auwera, B. J. PY - 2019 DA - 2019// TI - Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review JO - Eur J Endocrinol VL - 181 UR - https://doi.org/10.1530/EJE-19-0291 DO - 10.1530/EJE-19-0291 ID - Filette2019 ER - TY - JOUR AU - Hansen, E. AU - Sahasrabudhe, D. AU - Sievert, L. PY - 2016 DA - 2016// TI - A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome JO - Cancer Immunol Immunother VL - 65 UR - https://doi.org/10.1007/s00262-016-1835-4 DO - 10.1007/s00262-016-1835-4 ID - Hansen2016 ER - TY - JOUR AU - Ohara, N. AU - Kobayashi, M. AU - Ohashi, K. AU - Ito, R. AU - Ikeda, Y. AU - Kawaguchi, G. PY - 2019 DA - 2019// TI - Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature JO - J Med Case Rep VL - 13 UR - https://doi.org/10.1186/s13256-019-2002-2 DO - 10.1186/s13256-019-2002-2 ID - Ohara2019 ER - TY - JOUR AU - Percik, R. AU - Shlomai, G. AU - Tirosh, A. AU - Tirosh, A. AU - Leibowitz-Amit, R. AU - Eshet, Y. PY - 2020 DA - 2020// TI - Isolated autoimmune adrenocorticotropic hormone deficiency: from a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors JO - Autoimmun Rev VL - 19 UR - https://doi.org/10.1016/j.autrev.2019.102454 DO - 10.1016/j.autrev.2019.102454 ID - Percik2020 ER - TY - JOUR AU - Kitajima, K. AU - Ashida, K. AU - Wada, N. AU - Suetsugu, R. AU - Takeichi, Y. AU - Sakamoto, S. PY - 2017 DA - 2017// TI - Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab JO - Jpn J Clin Oncol VL - 47 UR - https://doi.org/10.1093/jjco/hyx018 DO - 10.1093/jjco/hyx018 ID - Kitajima2017 ER - TY - STD TI - National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE). Version 5.0. November 27, 2017. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf. Accessed 1 Apr 2020. UR - https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf ID - ref10 ER - TY - JOUR AU - Brahmer, J. R. AU - Lacchetti, C. AU - Schneider, B. J. AU - Atkins, M. B. AU - Brassil, K. J. AU - Caterino, J. M. PY - 2018 DA - 2018// TI - Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2017.77.6385 DO - 10.1200/JCO.2017.77.6385 ID - Brahmer2018 ER -